ECOG 1505 Study: No Benefit of Post-Operative Avastin in Early Stage Lung Cancer Patients - 100390

Spotlight
Video

ECOG 1505 Study: No Benefit of Post-Operative Avastin in Early Stage Lung Cancer Patients

cancergrace has 804 videos Subscribe Here

Loading........
Description: Drs. Ben Solomon, Leora Horn, & Jack West review trial result and implications of ECOG 1505 trial that showed no benefit to addition of Avastin (bevacizumab) to adjuvant chemotherapy for early stage NSCLC.
Shared By : cancergrace
Posted on : 10/30/15
Added : 2 years ago